{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32541811", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "12"}, "DateRevised": {"Year": "2021", "Month": "06", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "06", "Day": "15"}], "Language": ["eng"], "ELocationID": ["458", "10.1038/s41419-020-2575-0"], "Journal": {"ISSN": "2041-4889", "JournalIssue": {"Volume": "11", "Issue": "6", "PubDate": {"Year": "2020", "Month": "Jun", "Day": "15"}}, "Title": "Cell death & disease", "ISOAbbreviation": "Cell Death Dis"}, "ArticleTitle": "Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B/PDGFR-\u03b2 pathway in hepatic stellate cells.", "Pagination": {"StartPage": "458", "MedlinePgn": "458"}, "Abstract": {"AbstractText": ["Identifying effective anti-fibrotic therapies is a major clinical need that remains unmet. In the present study, roseotoxin B was shown to possess an improving effect on cholestatic liver fibrosis in bile duct-ligated mice, as proved by histochemical and immunohistochemical staining, hepatic biochemical parameters, and TUNEL apoptotic cell detection in tissue sections. Using cellular thermal shift assay, computational molecular docking, microscale thermophoresis technology, and surface plasmon resonance biosensor, we confirmed that PDGFR-\u03b2 was a direct target of roseotoxin B in fibrotic livers. Of note, human tissue microarrays detected pathologically high expression of p-PDGFR-\u03b2 in liver samples of ~80% of patients with liver fibrosis and cirrhosis. PDGF-B/PDGFR-\u03b2 pathway promotes transdifferentiation and excessive proliferation of hepatic stellate cells (HSCs), which is a very crucial driver for liver fibrosis. Meaningfully, roseotoxin B blocked the formation of PDGF-BB/PDGFR-\u03b2\u03b2 complex by targeting the D2 domain of PDGFR-\u03b2, thereby inhibiting the PDGF-B/PDGFR-\u03b2 pathway in HSCs. In summary, our study provided roseotoxin B as a unique candidate agent for the treatment of liver fibrosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, 221116, Jiangsu, China. xingqi_wang_njuer@163.com."}], "LastName": "Wang", "ForeName": "Xingqi", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cell Biology, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221009, Jiangsu, China."}], "LastName": "Gao", "ForeName": "Yuzhi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, 221116, Jiangsu, China."}], "LastName": "Li", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, 221116, Jiangsu, China."}], "LastName": "Huang", "ForeName": "Yuqing", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, 221116, Jiangsu, China."}], "LastName": "Zhu", "ForeName": "Yawen", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, 221116, Jiangsu, China."}], "LastName": "Lv", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, 221116, Jiangsu, China."}], "LastName": "Wang", "ForeName": "Ruzeng", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Genetic Medicine, Xuzhou Maternity and Child Health Care Hospital, Xuzhou, 221009, Jiangsu, China."}], "LastName": "Gou", "ForeName": "Lingshan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, 221116, Jiangsu, China."}], "LastName": "Cheng", "ForeName": "Chao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, 221116, Jiangsu, China."}], "LastName": "Feng", "ForeName": "Zhaojun", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, 221116, Jiangsu, China."}], "LastName": "Xie", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, 221116, Jiangsu, China. tj-085@163.com."}], "LastName": "Tian", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cell Biology, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221009, Jiangsu, China. wenxi_yao@163.com."}], "LastName": "Yao", "ForeName": "Ruiqin", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cell Death Dis", "NlmUniqueID": "101524092"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Depsipeptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Mycotoxins"}, {"RegistryNumber": "55466-29-0", "NameOfSubstance": "roseotoxin B"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Receptor, Platelet-Derived Growth Factor beta"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Depsipeptides"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hepatic Stellate Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pathology"], "DescriptorName": "Liver"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Liver Cirrhosis"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Mycotoxins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptor, Platelet-Derived Growth Factor beta"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "B\u00f6ttcher K, Pinzani M. Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents. Adv. Drug Deliv. Rev. 2017;121:3\u20138. doi: 10.1016/j.addr.2017.05.016.", "ArticleIdList": ["10.1016/j.addr.2017.05.016", "28600202"]}, {"Citation": "Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol. Asp. Med. 2019;65:37\u201355. doi: 10.1016/j.mam.2018.09.002.", "ArticleIdList": ["10.1016/j.mam.2018.09.002", "30213667"]}, {"Citation": "El-Serag HB. Hepatocellular carcinoma. N. Engl. J. Med. 2011;365:1118\u20131127. doi: 10.1056/NEJMra1001683.", "ArticleIdList": ["10.1056/NEJMra1001683", "21992124"]}, {"Citation": "El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264\u20131273.e1. doi: 10.1053/j.gastro.2011.12.061.", "ArticleIdList": ["10.1053/j.gastro.2011.12.061", "PMC3338949", "22537432"]}, {"Citation": "McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin. Liver Dis. 2015;19:223\u2013238. doi: 10.1016/j.cld.2015.01.001.", "ArticleIdList": ["10.1016/j.cld.2015.01.001", "PMC4712629", "25921660"]}, {"Citation": "Sun M, Kisseleva T. Reversibility of liver fibrosis. Clin. Res. Hepatol. Gastroenterol. 2015;39(Suppl 1):S60\u2013S63. doi: 10.1016/j.clinre.2015.06.015.", "ArticleIdList": ["10.1016/j.clinre.2015.06.015", "PMC4636085", "26206574"]}, {"Citation": "Campana L, Iredale JP. Regression of liver fibrosis. Semin. Liver Dis. 2017;37:1\u201310. doi: 10.1055/s-0036-1597816.", "ArticleIdList": ["10.1055/s-0036-1597816", "28201843"]}, {"Citation": "Zhang CY, Yuan WG, He P, Lei JH, Wang CX. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World J. Gastroenterol. 2016;22:10512\u201310522. doi: 10.3748/wjg.v22.i48.10512.", "ArticleIdList": ["10.3748/wjg.v22.i48.10512", "PMC5192262", "28082803"]}, {"Citation": "Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv. Drug Deliv. Rev. 2017;121:27\u201342. doi: 10.1016/j.addr.2017.05.007.", "ArticleIdList": ["10.1016/j.addr.2017.05.007", "PMC5682243", "28506744"]}, {"Citation": "Engstrom GW, DeLance JV, Richard JL, Baetz AL. Purification and characterization of roseotoxin b, a toxic cyclodepsipeptide from Trichothecium roseum. J. Agric. Food Chem. 1975;23:244\u2013253. doi: 10.1021/jf60198a050.", "ArticleIdList": ["10.1021/jf60198a050", "237028"]}, {"Citation": "Dowd PF, Cole RJ, Vesonder RF. Toxicity of selected tremorgenic mycotoxins and related compounds to Spodoptera frugiperda and Heliothis zea. J. Antibiot. 1988;41:1868\u20131872. doi: 10.7164/antibiotics.41.1868.", "ArticleIdList": ["10.7164/antibiotics.41.1868", "3209479"]}, {"Citation": "Tsunoo A, Kamijo M, Taketomo N, Sato Y, Ajisaka K. Roseocardin, a novel cardiotonic cyclodepsipeptide from Trichothecium roseum TT103. J. Antibiot. 1997;50:1007\u20131013. doi: 10.7164/antibiotics.50.1007.", "ArticleIdList": ["10.7164/antibiotics.50.1007", "9510906"]}, {"Citation": "Tsunoo A, Kamijo M. Non-cyclic AMP-dependent, positive inotropic cyclodepsipeptides with negative chronotropy. J. Pharmacol. Exp. Ther. 1999;290:1006\u20131012.", "ArticleIdList": ["10454471"]}, {"Citation": "Wang XQ, et al. Roseotoxin B improves allergic contact dermatitis through a unique anti-inflammatory mechanism involving excessive activation of autophagy in activated T lymphocytes. J. Invest. Dermatol. 2016;136:1636\u20131646. doi: 10.1016/j.jid.2016.04.017.", "ArticleIdList": ["10.1016/j.jid.2016.04.017", "27155460"]}, {"Citation": "Borkham-Kamphorst E, Weiskirchen R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev. 2016;28:53\u201361. doi: 10.1016/j.cytogfr.2015.10.002.", "ArticleIdList": ["10.1016/j.cytogfr.2015.10.002", "26547628"]}, {"Citation": "Papadopoulos N, Lennartsson J. The PDGF/PDGFR pathway as a drug target. Mol. Asp. Med. 2018;62:75\u201388. doi: 10.1016/j.mam.2017.11.007.", "ArticleIdList": ["10.1016/j.mam.2017.11.007", "29137923"]}, {"Citation": "Wang XQ, et al. A new pharmacological effect of levornidazole: inhibition of NLRP3 inflammasome activation. Biochem. Pharmacol. 2015;97:178\u2013188. doi: 10.1016/j.bcp.2015.06.030.", "ArticleIdList": ["10.1016/j.bcp.2015.06.030", "26212544"]}, {"Citation": "Wang XQ, et al. Trichomide A, a natural cyclodepsipeptide, exerts immunosuppressive activity against activated T lymphocytes by upregulating SHP2 activation to overcome contact dermatitis. J. Invest. Dermatol. 2014;134:2737\u20132746. doi: 10.1038/jid.2014.252.", "ArticleIdList": ["10.1038/jid.2014.252", "24933319"]}, {"Citation": "Martinez MolinaD, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 2013;341:84\u201387. doi: 10.1126/science.1233606.", "ArticleIdList": ["10.1126/science.1233606", "23828940"]}, {"Citation": "Jafari R, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 2014;9:2100\u20132122. doi: 10.1038/nprot.2014.138.", "ArticleIdList": ["10.1038/nprot.2014.138", "25101824"]}, {"Citation": "Krzywinski M, Altman N. Power and sample size. Nat. Methods. 2013;10:1139\u20131140. doi: 10.1038/nmeth.2738.", "ArticleIdList": ["10.1038/nmeth.2738"]}, {"Citation": "Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 2004;39:273\u2013278. doi: 10.1002/hep.20051.", "ArticleIdList": ["10.1002/hep.20051", "14767974"]}, {"Citation": "Sheen JM, et al. Melatonin alleviates liver apoptosis in bile duct ligation young rats. Int. J. Mol. Sci. 2016;17:1365. doi: 10.3390/ijms17081365.", "ArticleIdList": ["10.3390/ijms17081365", "PMC5000760", "27556445"]}, {"Citation": "Marques TG, et al. Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection. Acta Cir. Bras. 2012;27:589\u2013594. doi: 10.1590/S0102-86502012000800013.", "ArticleIdList": ["10.1590/S0102-86502012000800013", "22850713"]}, {"Citation": "Tag, C. G. et al. Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis. J. Vis. Exp. 52438 (2015).", "ArticleIdList": ["PMC4354634", "25741630"]}, {"Citation": "Zhang K, et al. The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition. Theranostics. 2019;9:7566\u20137582. doi: 10.7150/thno.36942.", "ArticleIdList": ["10.7150/thno.36942", "PMC6831459", "31695787"]}, {"Citation": "Gehrke N, et al. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation. Am. J. Physiol. Gastrointest. Liver Physiol. 2018;314:G319\u2013G333. doi: 10.1152/ajpgi.00097.2017.", "ArticleIdList": ["10.1152/ajpgi.00097.2017", "29191940"]}, {"Citation": "Hikita H, et al. Mcl-1 and Bcl-xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver. Hepatology. 2009;50:1217\u20131226. doi: 10.1002/hep.23126.", "ArticleIdList": ["10.1002/hep.23126", "PMC3560852", "19676108"]}, {"Citation": "Motoi S, et al. Anti-apoptotic effects of recombinant human hepatocyte growth factor on hepatocytes were associated with intrahepatic hemorrhage suppression indicated by the preservation of prothrombin time. Int. J. Mol. Sci. 2019;20:1821. doi: 10.3390/ijms20081821.", "ArticleIdList": ["10.3390/ijms20081821", "PMC6514566", "31013780"]}, {"Citation": "Wang YT, et al. Hepatocyte TNF receptor-associated factor 6 aggravates hepatic inflammation and fibrosis by promoting lysine 6-linked polyubiquitination of apoptosis signal-regulating kinase 1. Hepatology. 2020;71:93\u2013111. doi: 10.1002/hep.30822.", "ArticleIdList": ["10.1002/hep.30822", "31222801"]}, {"Citation": "Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 2017;14:397\u2013411. doi: 10.1038/nrgastro.2017.38.", "ArticleIdList": ["10.1038/nrgastro.2017.38", "28487545"]}, {"Citation": "Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004;15:255\u2013273. doi: 10.1016/j.cytogfr.2004.03.006.", "ArticleIdList": ["10.1016/j.cytogfr.2004.03.006", "15207816"]}, {"Citation": "Haghgoo SM, Sharafi H, Alavian SM. Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review. Clin. Chem. Lab. Med. 2019;57:577\u2013610. doi: 10.1515/cclm-2018-0357.", "ArticleIdList": ["10.1515/cclm-2018-0357", "30231008"]}, {"Citation": "Mederacke I, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat. Commun. 2013;4:2823. doi: 10.1038/ncomms3823.", "ArticleIdList": ["10.1038/ncomms3823", "PMC4059406", "24264436"]}]}], "History": [{"Year": "2020", "Month": "2", "Day": "7"}, {"Year": "2020", "Month": "4", "Day": "22"}, {"Year": "2020", "Month": "4", "Day": "22"}, {"Year": "2020", "Month": "6", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["32541811", "PMC7296008", "10.1038/s41419-020-2575-0", "10.1038/s41419-020-2575-0"]}}]}